Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission
Kristin Page(Medical College of Wisconsin), Vanderson Rocha(European Organisation for Rare Diseases), Jesse D. Troy(Duke Medical Center), Peter Bader(Goethe University Frankfurt), Fernanda Volt(Université Paris Cité), Myriam Labopin(Sorbonne Université), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Tracey O’Brien(Sydney Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Joanne Kurtzberg(Duke University), Ajay Vora(Great Ormond Street Hospital), Annalisa Ruggeri(Inserm), Mouhab Ayas(King Faisal Specialist Hospital & Research Centre), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Gérard Michel(Hôpital d'Enfants), Carmen Bonfim(Hospital de Clínicas Universidade Federal do Paraná), Alessandra Picardi(University of Rome Tor Vergata)
Cited by 31
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606